In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Algorithm SAL sells Cardiome's Brinavess in the Middle East and Africa

Executive Summary

Lebanon-based pharmaceutical manufacturer Algorithm SAL will exclusively market Cardiome Pharma Corp.’s Brinavess (vernakalant intravenous) in certain Middle Eastern and North African countries, including Algeria, Bahrain, Egypt, Iran, Jordan, Saudi Arabia, Kuwait, Lebanon, Libya, Morocco, Oman, Qatar, Tunisia, and United Arab Emirates.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Alliance
    • Marketing (Licensing)

Related Companies